Biocon Biologics gets positive CHMP opinion for YESAFILI, biosimilar Aflibercept
YESAFILI is intended for the treatment of neovascular age-related macular degeneration, visual impairment due to macular oedema…
Recover your password.
A password will be e-mailed to you.